| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656720 | 43523 | DEPRELIO 25 mg CAPSULAS DURAS | DEPRELIO 25 mg CAPSULAS DURAS , 30 cápsulas | 25 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/43523/43523_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/43523/43523_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 953 | LABORATORIO ALDO UNION S.L. | 1966-10-01 | 1 | 1 | 1 | 1966-10-01 | 2008-01-16 | 0 | 2012-01-02 | 790733 | View Edit Delete | |||||||||||
| 656211 | 68096 | METAMIZOL STADA 575 mg CAPSULAS DURAS EFG | METAMIZOL STADA 575 mg CAPSULAS DURAS EFG, 20 cápsulas | 575 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68096/68096_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68096/68096_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2006-10-24 | 1 | 1 | 1 | 2006-10-24 | 2006-10-24 | 0 | 2011-02-17 | View Edit Delete | ||||||||||||
| 656262 | 68116 | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG, 10 cápsulas | 575 mg | 5 | 10 | 43 | 10 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68116/68116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68116/68116_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2006-10-30 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656263 | 68116 | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG | METAMIZOL CINFA 575 mg CAPSULAS DURAS EFG, 20 cápsulas | 575 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68116/68116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68116/68116_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-10-30 | 1 | 1 | 1 | 2006-10-30 | 2006-10-30 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656367 | 68167 | METFORMINA CINFA 850 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | METFORMINA CINFA 850 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 50 comprimidos | 850 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68167/68167_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68167/68167_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-11-15 | 1 | 1 | 1 | 2006-11-15 | 2006-11-15 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656428 | 68201 | TRIFLUSAL CINFA 300 mg CAPSULAS DURAS EFG | TRIFLUSAL CINFA 300 mg CAPSULAS DURAS EFG, 50 cápsulas | 300 mg | 5 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68201/68201_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68201/68201_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-02-01 | 1 | 1 | 1 | 2007-02-01 | 2007-02-01 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 656733 | 50893 | FOSFOCINA 500 MG CAPSULAS DURAS | FOSFOCINA 500 MG CAPSULAS DURAS, 12 cápsulas | 500 mg | 5 | 12 | 43 | 12 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50893/50893_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50893/50893_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1973-02-01 | 1 | 1 | 1 | 1973-02-01 | 2007-12-17 | 0 | 2011-09-09 | 759696 | View Edit Delete | |||||||||||
| 656734 | 50893 | FOSFOCINA 500 MG CAPSULAS DURAS | FOSFOCINA 500 MG CAPSULAS DURAS, 24 cápsulas | 500 mg | 5 | 24 | 43 | 24 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50893/50893_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50893/50893_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1973-02-01 | 1 | 1 | 1 | 1973-02-01 | 2007-12-17 | 0 | 2011-09-09 | 759704 | View Edit Delete | |||||||||||
| 656560 | 18498 | MYSOLINE 250 MG COMPRIMIDOS | MYSOLINE 250 MG COMPRIMIDOS , 100 comprimidos | 250 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/18498/18498_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/18498/18498_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 71545 | LABORATORIOS RUBIO S.A. | 1953-02-01 | 1 | 1 | 1 | 1953-02-01 | 2007-07-10 | 0 | 2012-01-02 | 790626 | View Edit Delete | |||||||||||
| 656938 | 06342001 | NEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | NEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 comprimidos | 200 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06342001/06342001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06342001/06342001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2006-08-01 | 1 | 1 | 1 | 2006-08-01 | 2009-12-23 | 0 | 2011-10-10 | 654364 | View Edit Delete | |||||||||||
| 654856 | 06371019 | DAFIRO 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06371019/06371019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06371019/06371019_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2007-04-02 | 1 | 1 | 1 | 2007-04-02 | 2014-03-17 | 0 | 2011-02-24 | 671927 | View Edit Delete | |||||||||||
| 654857 | 06371011 | DAFIRO 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06371011/06371011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06371011/06371011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2007-04-02 | 1 | 1 | 1 | 2007-04-02 | 2014-03-17 | 0 | 2011-02-24 | 671928 | View Edit Delete | |||||||||||
| 656476 | 68224 | METAMIZOL KERN PHARMA 575 mg CAPSULAS DURAS EFG | METAMIZOL KERN PHARMA 575 mg CAPSULAS DURAS EFG, 20 cápsulas | 575 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68224/68224_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68224/68224_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-12-04 | 1 | 1 | 1 | 2006-12-04 | 2006-12-04 | 0 | 2011-10-17 | View Edit Delete | ||||||||||||
| 658256 | 68339 | PARACETAMOL KERN PHARMA 1 g COMPRIMIDOS EFG | PARACETAMOL KERN PHARMA 1 g COMPRIMIDOS EFG, 20 comprimidos | 1.000 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68339/68339_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68339/68339_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-01-23 | 1 | 1 | 1 | 2007-01-23 | 2007-01-23 | 0 | 2011-02-16 | View Edit Delete | ||||||||||||
| 658257 | 68339 | PARACETAMOL KERN PHARMA 1 g COMPRIMIDOS EFG | PARACETAMOL KERN PHARMA 1 g COMPRIMIDOS EFG, 40 comprimidos | 1.000 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68339/68339_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68339/68339_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-01-23 | 1 | 1 | 1 | 2007-01-23 | 2007-01-23 | 0 | 2011-02-16 | View Edit Delete | ||||||||||||
| 656124 | 48905 | ALGI-MABO 500 MG CÁPSULAS DURAS | ALGI-MABO 500 MG CÁPSULAS DURAS , 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48905/48905_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48905/48905_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 1970-02-01 | 1 | 1 | 1 | 1970-02-01 | 1998-06-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656290 | 68128 | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68128/68128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68128/68128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2006-11-02 | 1 | 1 | 1 | 2006-11-02 | 2006-11-02 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 654858 | 09574014 | DAFIRO HCT 10 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 10 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574014/09574014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574014/09574014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-04-29 | 2014-03-17 | 0 | 2011-02-24 | 665775 | View Edit Delete | |||||||||||
| 654859 | 09574038 | DAFIRO HCT 10 mg/160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 10 mg/160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574038/09574038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574038/09574038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-03-29 | 2014-03-17 | 0 | 2011-02-24 | 665777 | View Edit Delete | |||||||||||
| 654860 | 09574002 | DAFIRO HCT 5 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | DAFIRO HCT 5 mg/160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09574002/09574002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09574002/09574002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | ESTEVE PHARMACEUTICALS S.A. | 2010-03-29 | 1 | 1 | 1 | 2010-03-29 | 2014-03-17 | 0 | 2011-02-24 | 665774 | View Edit Delete |
Page 44 of 1036, showing 20 records out of 20715 total, starting on record 861, ending on 880